• 1
    Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002; 51(10): 29442950.
  • 2
    Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004; 350(7): 664671.
  • 3
    Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005; 54(1): 814.
  • 4
    Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003; 300(5622): 11401142.
  • 5
    Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, Nair KS. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. USA. 2005; 102(15): 56185623.
  • 6
    Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, Pypaert M, Shulman GI. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 2005; 115(12): 35873593.
  • 7
    Lebon V, Dufour S, Petersen KF, Ren J, Jucker BM, Slezak LA, Cline GW, Rothman DL, Shulman GI. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J. Clin. Invest. 2001; 108(5): 733737.
  • 8
    Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes. 2006; 55(1): 136140.
  • 9
    Trenell MI, Hollingsworth KG, Lim EL, Taylor R. Increased daily walking improves lipid oxidation without changes in mitochondrial function in type 2 diabetes. Diabetes Care. 2008; 31(8): 16441649.
  • 10
    Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med. 2005; 2(9): e233.
  • 11
    Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, Krssak M, Nowotny P, Wolzt M, Waldhausl W, Roden M. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med. 2007; 4(5): e154.
  • 12
    Ritov VB, Menshikova EV, Azuma K, Wood RJ, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am. J. Physiol. Endocrinol. Metab. 2010; 298(1): e4958.
  • 13
    Pagel-Langenickel I, Bao J, Pang L, Sack MN. The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance. Endocr. Rev. 2010; 31(1): 2551.
  • 14
    Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim. Biophys. Acta (BBA)-Molecular and Cell Biology of Lipids 2010; 1801(3): 266271.
  • 15
    Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn. Reson. Med. 1984; 1(3): 307315.
  • 16
    Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand. J. Clin. Lab. Invest. 1974; 33(2): 109120.
  • 17
    Forsen F, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J. Chem. Phys. 1963; 39: 28922901.
  • 18
    Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput. Biol. Med. 2001; 31(4): 269286.
  • 19
    Vanhamme L, Van Huffel S, Van Hecke P, van Ormondt D. Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals. J. Magn. Reson. 1999; 140(1): 120130.
  • 20
    DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979; 237(3): E214223.
  • 21
    Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am. J. Physiol. 1981; 240(6): E630639.
  • 22
    Field A. Discovering statistics using SPSS: SAGE Publications. 2005.
  • 23
    Bonadonna RC, del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA. Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. Am. J. Physiol. 1993; 265 (6 Pt 1): E943953.
  • 24
    Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 1990; 322(4): 223228.
  • 25
    Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 1996; 97(12): 28592865.
  • 26
    Molina AJ, Wikstrom JD, Stiles L, Las G, Mohamed H, Elorza A, Walzer G, Twig G, Katz S, Corkey BE, Shirihai OS. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes. 2009; 58(10): 23032315.
  • 27
    Yang JY, Yeh HY, Lin K, Wang PH. Insulin stimulates Akt translocation to mitochondria: implications on dysregulation of mitochondrial oxidative phosphorylation in diabetic myocardium. J. Mol. Cell. Cardiol. 2009; 46(6): 919926.
  • 28
    Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. USA. 2003; 100(13): 79968001.
  • 29
    Befroy DE, Petersen KF, Shulman GI, Rothman DL. Localized 31P saturation transfer reveals differences in gastrocnemius and soleus rates of ATP synthesis in-vivo. Proc ISMRM. 2008(16): 2565.
  • 30
    Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, Waldhausl W. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999; 48(2): 358364.
  • 31
    Bose S, French S, Evans FJ, Joubert F, Balaban RS. Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J. Biol. Chem. 2003; 278(40): 3915539165.
  • 32
    Brindle K, Krikler S. P-31-NMR saturation transfer measurements of phosphate consumption in Saccharomyces-Cerevisiae. Biochimica et Biophysica Acta. 1985; 847(3): 285292.
  • 33
    Ugurbil K, Kingsleyhickman PB, Sako EY, Zimmer S, Mohanakrishnan P, Robitaille PML, Thoma WJ, Johnson A, Foker JE, From AHL. P-31-NMR studies of the kinetics and regulation of oxidative-phosphorylation in the intact myocardium. Ann. NY Acad. Sci. 1987; 508: 265286.
  • 34
    Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes. 1995; 44(9): 10101020.
  • 35
    Laurent D. Reply to Kemp: a clarification on the interpretation of muscular ATP synthase flux data obtained by P-31 saturation transfer. Am. J. Physiol. Endocrinol. Metab. 2008; 294(3): E643E644.
  • 36
    De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, Prompers JJ. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur. J. Endocrinol. 2008; 158(5): 643653.
  • 37
    Turner N, Heilbronn LK. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol. Metab. 2008; 19(9): 324330.